BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Valla D. Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West. J Gastroenterol Hepatol 2004;19:S204-11. [DOI: 10.1111/j.1440-1746.2004.03642.x] [Cited by in Crossref: 104] [Cited by in F6Publishing: 57] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Bittencourt PL, Couto CA, Ribeiro DD. Portal Vein Thrombosis and Budd–Chiari Syndrome. Clinics in Liver Disease 2009;13:127-44. [DOI: 10.1016/j.cld.2008.10.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
2 Rajani R, Melin T, Björnsson E, Broomé U, Sangfelt P, Danielsson Å, Gustavsson A, Grip O, Svensson H, Lööf L, Wallerstedt S, Almer SH. Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience. Liver International 2009;29:253-9. [DOI: 10.1111/j.1478-3231.2008.01838.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 67] [Article Influence: 7.2] [Reference Citation Analysis]
3 Boskovic A, Kitic I, Stankovic I, Prokic D, Zlatar N. Primary Budd–Chiari syndrome in a 3-year-old boy with homozygous factor V Leiden G1691A mutation. Eur J Pediatr 2014;173:393-5. [DOI: 10.1007/s00431-013-2031-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 De Stefano V, Qi X, Betti S, Rossi E. Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment. Thromb Haemost 2016;115:240-9. [PMID: 26333846 DOI: 10.1160/TH15-04-0326] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 6.2] [Reference Citation Analysis]
5 Pahari H, Chaudhary RJ, Thiagarajan S, Raut V, Babu R, Bhangui P, Goja S, Rastogi A, Vohra V, Soin AS. Hepatic Venous and Inferior Vena Cava Morphology No Longer a Barrier to Living Donor Liver Transplantation for Budd-Chiari Syndrome: Surgical Techniques and Outcomes. Transplant Proc. 2016;48:2732-2737. [PMID: 27788809 DOI: 10.1016/j.transproceed.2016.08.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
6 Valla DC. Primary Budd-Chiari syndrome. J Hepatol. 2009;50:195-203. [PMID: 19012988 DOI: 10.1016/j.jhep.2008.10.007] [Cited by in Crossref: 214] [Cited by in F6Publishing: 140] [Article Influence: 16.5] [Reference Citation Analysis]
7 Alukal JJ, Zhang T, Thuluvath PJ. Outcomes of status 1 liver transplantation for Budd-Chiari Syndrome with fulminant hepatic failure. Am J Transplant. 2020;. [PMID: 33236517 DOI: 10.1111/ajt.16410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Park H, Yoon JY, Park KH, Kim DY, Ahn SH, Han KH, Chon CY, Park JY. Hepatocellular carcinoma in Budd-Chiari syndrome: A single center experience with long-term follow-up in South Korea. World J Gastroenterol 2012; 18(16): 1946-1952 [PMID: 22563176 DOI: 10.3748/wjg.v18.i16.1946] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
9 Paul SB, Shalimar, Sreenivas V, Gamanagatti SR, Sharma H, Dhamija E, Acharya SK. Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction. Aliment Pharmacol Ther. 2015;41:961-971. [PMID: 25809735 DOI: 10.1111/apt.13173] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
10 Valla DC. Thrombosis and anticoagulation in liver disease. Hepatology 2008;47:1384-93. [DOI: 10.1002/hep.22192] [Cited by in Crossref: 77] [Cited by in F6Publishing: 57] [Article Influence: 5.9] [Reference Citation Analysis]
11 Bittencourt PL, Couto CA, Ribeiro DD. Portal Vein Thrombosis and Budd–Chiari Syndrome. Hematology/Oncology Clinics of North America 2011;25:1049-66. [DOI: 10.1016/j.hoc.2011.09.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Donadini MP, Ageno W. Unusual site thrombosis. Semin Hematol 2011;48:264-70. [PMID: 22000092 DOI: 10.1053/j.seminhematol.2011.08.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
13 Alukal JJ, Zhang T, Thuluvath PJ. Mortality and health care burden of Budd Chiari syndrome in the United States: A nationwide analysis (1998-2017). World J Hepatol 2021; 13(6): 686-698 [PMID: 34239703 DOI: 10.4254/wjh.v13.i6.686] [Reference Citation Analysis]
14 Donadini MP, Squizzato A, Ageno W. Treating patients with cancer and acute venous thromboembolism. Expert Opinion on Pharmacotherapy 2015;17:535-43. [DOI: 10.1517/14656566.2016.1124857] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Roberts LN, Patel RK, Arya R. Haemostasis and thrombosis in liver disease. British Journal of Haematology 2010;148:507-21. [DOI: 10.1111/j.1365-2141.2009.08021.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 6.5] [Reference Citation Analysis]
16 Karaca C, Yilmaz C, Ferecov R, Iakobadze Z, Kilic K, Caglayan L, Aydogdu S, Kilic M. Living-Donor Liver Transplantation for Budd-Chiari Syndrome: Case Series. Transplant Proc. 2017;49:1841-1847. [PMID: 28923635 DOI: 10.1016/j.transproceed.2017.04.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
17 Sakr M, Barakat E, Abdelhakam S, Dabbous H, Yousuf S, Shaker M, Eldorry A. Epidemiological aspects of Budd-Chiari in Egyptian patients: A single-center study. World J Gastroenterol 2011; 17(42): 4704-4710 [PMID: 22180713 DOI: 10.3748/wjg.v17.i42.4704] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
18 Clark PJ, Slaughter RE, Radford DJ. Systemic thrombolysis for acute, severe Budd-Chiari syndrome. J Thromb Thrombolysis 2012;34:410-5. [DOI: 10.1007/s11239-012-0760-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
19 Ollivier-hourmand I, Allaire M, Goutte N, Morello R, Chagneau-derrode C, Goria O, Dumortier J, Cervoni JP, Dharancy S, Ganne-carrié N, Bureau C, Carbonell N, Abergel A, Nousbaum JB, Anty R, Barraud H, Ripault MP, De Ledinghen V, Minello A, Oberti F, Radenne S, Bendersky N, Farges O, Archambeaud I, Guillygomarc’h A, Ecochard M, Ozenne V, Hilleret MN, Nguyen-khac E, Dauvois B, Perarnau JM, Lefilliatre P, Raabe JJ, Doffoel M, Becquart JP, Saillard E, Valla D, Dao T, Plessier A. The epidemiology of Budd–Chiari syndrome in France. Digestive and Liver Disease 2018;50:931-7. [DOI: 10.1016/j.dld.2018.04.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
20 Seijo S, Garcia-pagan JC. An overview of current treatment methods for Budd–Chiari syndrome. Expert Opinion on Orphan Drugs 2014;2:147-57. [DOI: 10.1517/21678707.2014.872560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Shalimar, Gamanagatti SR, Patel AH, Kedia S, Nayak B, Gunjan D, Ranjan G, Paul SB, Acharya SK. Long-term outcomes of transjugular intrahepatic portosystemic shunt in Indian patients with Budd-Chiari syndrome. Eur J Gastroenterol Hepatol. 2017;29:1174-1182. [PMID: 28763339 DOI: 10.1097/meg.0000000000000945] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
22 Riva N, Dentali F, Donadini MP, Squizzato A, Ageno W. Risk of recurrence of unusual site venous thromboembolism. Hamostaseologie 2017;33:225-31. [DOI: 10.5482/hamo-13-03-0006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
23 Martín-llahí M, Albillos A, Bañares R, Berzigotti A, García-criado MÁ, Genescà J, Hernández-gea V, Llop-herrera E, Masnou-ridaura H, Mateo J, Navascués CA, Puente Á, Romero-gutiérrez M, Simón-talero M, Téllez L, Turon F, Villanueva C, Zarrabeitia R, García-pagán JC. Enfermedades vasculares del hígado. Guías Clínicas de la Sociedad Catalana de Digestología y de la Asociación Española para el Estudio del Hígado. Gastroenterología y Hepatología 2017;40:538-80. [DOI: 10.1016/j.gastrohep.2017.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
24 Ishikawa M, Sakamoto A. Open Cardiac Surgery in a Patient With Chronic Budd-Chiari Syndrome. J Cardiothorac Vasc Anesth 2021;35:3042-4. [PMID: 33358289 DOI: 10.1053/j.jvca.2020.11.063] [Reference Citation Analysis]
25 Bedossa P, Hytiroglou P, Yeh MM. Vascular Disorders. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 636-72. [DOI: 10.1016/b978-0-7020-6697-9.00011-x] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
26 Faraoun SA, Boudjella Mel A, Debzi N, Benidir N, Afredj N, Guerrache Y, Bentabak K, Soyer P, Bendib SE. Budd-Chiari syndrome: an update on imaging features. Clin Imaging 2016;40:637-46. [PMID: 27317208 DOI: 10.1016/j.clinimag.2016.01.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
27 Qi X, Yang Z, Bai M, Shi X, Han G, Fan D. Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis: Meta-analysis: JAK2V617F mutation in BCS and PVST. Alimentary Pharmacology & Therapeutics 2011;33:1087-103. [DOI: 10.1111/j.1365-2036.2011.04627.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
28 Qi X, Yang M, Fan D, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: a critical review of literatures. Scand J Gastroenterol. 2013;48:771-784. [PMID: 23506234 DOI: 10.3109/00365521.2013.777775] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
29 Han G, Qi X, Zhang W, He C, Yin Z, Wang J, Xia J, Xu K, Guo W, Niu J, Wu K, Fan D. Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center. Radiology. 2013;266:657-667. [PMID: 23143028 DOI: 10.1148/radiol.12120856] [Cited by in Crossref: 87] [Cited by in F6Publishing: 57] [Article Influence: 9.7] [Reference Citation Analysis]
30 Qi X, Ren W, Wang Y, Guo X, Fan D. Survival and prognostic indicators of Budd-Chiari syndrome: a systematic review of 79 studies. Expert Rev Gastroenterol Hepatol. 2015;9:865-875. [PMID: 25754880 DOI: 10.1586/17474124.2015.1024224] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
31 Seijo S, Plessier A, Hoekstra J, Dell'era A, Mandair D, Rifai K, Trebicka J, Morard I, Lasser L, Abraldes JG, Darwish Murad S, Heller J, Hadengue A, Primignani M, Elias E, Janssen HL, Valla DC, Garcia-Pagan JC;  European Network for Vascular Disorders of the Liver. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology. 2013;57:1962-1968. [PMID: 23389867 DOI: 10.1002/hep.26306] [Cited by in Crossref: 174] [Cited by in F6Publishing: 114] [Article Influence: 21.8] [Reference Citation Analysis]
32 Ghaffar TYA, Elfaramawy AA, el Saied S, el Adawy M, Sakr MA, Zalata K. Hepatic Venous Outflow Obstruction Complicating Churg-Strauss Syndrome in a 5-year-old Child. Journal of Pediatric Gastroenterology & Nutrition 2011;52:217-8. [DOI: 10.1097/mpg.0b013e3181f507d7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Yoo E, Jang J, Park K, Gwak G, Kim H, Kim S, Kim D. Prevalence of overt myeloproliferative neoplasms and JAK2 V617F mutation in Korean patients with splanchnic vein thrombosis: THE JAK2 V617F MUTATION IN KOREAN PATIENTS WITH SVT. International Journal of Laboratory Hematology 2011. [DOI: 10.1111/j.1751-553x.2011.01308.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Martinelli I, Franchini M, Mannucci PM. How I treat rare venous thromboses. Blood 2008;112:4818-23. [DOI: 10.1182/blood-2008-07-165969] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
35 Li Y, De Stefano V, Li H, Zheng K, Bai Z, Guo X, Qi X. Epidemiology of Budd-Chiari syndrome: A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 2019;43:468-74. [PMID: 30528513 DOI: 10.1016/j.clinre.2018.10.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
36 Ye QB, Huang QF, Luo YC, Wen YL, Chen ZK, Wei AL. Budd-Chiari syndrome associated with liver cirrhosis: A case report. World J Clin Cases 2021; 9(12): 2937-2943 [PMID: 33969080 DOI: 10.12998/wjcc.v9.i12.2937] [Reference Citation Analysis]
37 Shatzel JJ, O'Donnell M, Olson SR, Kearney MR, Daughety MM, Hum J, Nguyen KP, DeLoughery TG. Venous thrombosis in unusual sites: A practical review for the hematologist. Eur J Haematol 2019;102:53-62. [PMID: 30267448 DOI: 10.1111/ejh.13177] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
38 Pavri TM, Herbst A, Reddy R, Forde KA. Budd-Chiari syndrome: A single-center experience. World J Gastroenterol 2014; 20(43): 16236-16244 [PMID: 25473178 DOI: 10.3748/wjg.v20.i43.16236] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
39 Singhal D, de Castro S, Goyal N, Gouma DJ, Chaudhary A, van Gulik TM. Current role of portosystemic shunt surgery in the management of hepatic venous outflow obstruction. Dig Surg 2006;23:358-69. [PMID: 17164547 DOI: 10.1159/000097897] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
40 Plessier A, Rautou PE, Valla DC. Management of hepatic vascular diseases. J Hepatol 2012;56 Suppl 1:S25-38. [PMID: 22300463 DOI: 10.1016/S0168-8278(12)60004-X] [Cited by in Crossref: 132] [Cited by in F6Publishing: 38] [Article Influence: 14.7] [Reference Citation Analysis]
41 Rosenblatt R, Brown RS. Nonviral or Drug-Induced Etiologies of Acute Liver Failure. Clinics in Liver Disease 2018;22:347-60. [DOI: 10.1016/j.cld.2018.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
42 Qi X, Han G, Guo X, De Stefano V, Xu K, Lu Z, Xu H, Mancuso A, Zhang W, Han X. Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China. Aliment Pharmacol Ther. 2016;44:1152-1167. [PMID: 27734511 DOI: 10.1111/apt.13815] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 8.2] [Reference Citation Analysis]
43 Zhang W, Wang QZ, Chen XW, Zhong HS, Zhang XT, Chen XD, Xu K. Budd-Chiari syndrome in China: A 30-year retrospective study on survival from a single center. World J Gastroenterol 2018; 24(10): 1134-1143 [PMID: 29563757 DOI: 10.3748/wjg.v24.i10.1134] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
44 Qi X, Guo W, He C, Zhang W, Wu F, Yin Z, Bai M, Niu J, Yang Z, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre. Liver Int. 2014;34:1164-1175. [PMID: 24256572 DOI: 10.1111/liv.12355] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
45 Rautou PE, Moucari R, Escolano S, Cazals-Hatem D, Denié C, Chagneau-Derrode C, Charpignon C, Lédinghen Vd, Grenouillet-Delacre M, Habersetzer F, Nousbaum JB, Denninger MH, Valla DC, Plessier A. Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management. Am J Gastroenterol. 2009;104:1140-1146. [PMID: 19337247 DOI: 10.1038/ajg.2009.63] [Cited by in Crossref: 48] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
46 Shin N, Kim YH, Xu H, Shi HB, Zhang QQ, Colon Pons JP, Kim D, Xu Y, Wu FY, Han S, Lee BB, Li LS. Redefining Budd-Chiari syndrome: A systematic review. World J Hepatol 2016; 8(16): 691-702 [PMID: 27326316 DOI: 10.4254/wjh.v8.i16.691] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
47 Sakr M, Abdelhakam SM, Elsayed SA, Allam EH, Farid AM, Abdelmoaty W, Hassan AM, Shaker M, El-Gharib M, Eldorry A. Validation of prognostic indices in Egyptian Budd-Chiari syndrome patients: A single-center study. World J Gastroenterol 2017; 23(4): 629-637 [PMID: 28216969 DOI: 10.3748/wjg.v23.i4.629] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
48 De Stefano V, Martinelli I. Abdominal thromboses of splanchnic, renal and ovarian veins. Best Pract Res Clin Haematol 2012;25:253-64. [PMID: 22959542 DOI: 10.1016/j.beha.2012.07.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
49 Shalimar, Kumar A, Kedia S, Sharma H, Gamanagatti SR, Gulati GS, Nayak B, Thakur B, Acharya SK. Hepatic venous outflow tract obstruction: treatment outcomes and development of a new prognostic score. Aliment Pharmacol Ther 2016;43:1154-67. [PMID: 27060876 DOI: 10.1111/apt.13604] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
50 Donadini MP, Dentali F, Ageno W. Splanchnic vein thrombosis: new risk factors and management. Thromb Res 2012;129 Suppl 1:S93-6. [PMID: 22682143 DOI: 10.1016/S0049-3848(12)70025-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
51 Gao X, Gui E, Lu Z, Ning X, Zu M, Zhang P, Sun G. Risk factors of recurrence among 471 Chinese patients with Budd-Chiari syndrome. Clin Res Hepatol Gastroenterol. 2015;39:620-626. [PMID: 25656980 DOI: 10.1016/j.clinre.2014.12.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
52 Iwasaki T, Kawai H, Oseki K, Togashi T, Shioji K, Yamamoto S, Sato Y, Suzuki K, Toba K, Nomoto M, Hatakeyama K, Aoyagi Y. Japanese case of Budd-Chiari syndrome due to hepatic vein thrombosis successfully treated with liver transplantation. Hepatol Res 2012;42:213-8. [PMID: 22248193 DOI: 10.1111/j.1872-034X.2011.00913.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
53 Qi X, Zhang C, Han G, Zhang W, He C, Yin Z, Liu Z, Bai W, Li R, Bai M, Yang Z, Wu K, Fan D. Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study. J Gastroenterol Hepatol. 2012;27:1036-1043. [PMID: 22142461 DOI: 10.1111/j.1440-1746.2011.07040.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 6.2] [Reference Citation Analysis]
54 Khan F, Armstrong MJ, Mehrzad H, Chen F, Neil D, Brown R, Cain O, Tripathi D. Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome. Aliment Pharmacol Ther. 2019;49:840-863. [PMID: 30828850 DOI: 10.1111/apt.15149] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
55 Faraoun SA, Boudjella Mel A, Debzi N, Afredj N, Guerrache Y, Benidir N, Bouzid C, Bentabak K, Soyer P, Bendib SE. Budd-Chiari syndrome: a prospective analysis of hepatic vein obstruction on ultrasonography, multidetector-row computed tomography and MR imaging. Abdom Imaging. 2015;40:1500-1509. [PMID: 25687630 DOI: 10.1007/s00261-015-0380-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
56 Stempak-Droissart T, Rousset-Jablonski C, Spritzer PM, Lalhou N, Larger E, Pichard C, Plessier A, Gompel A. Impact of vascular liver disease on the menstrual cycle and metabolic status in premenopausal women. Clin Res Hepatol Gastroenterol 2021;:101756. [PMID: 34303004 DOI: 10.1016/j.clinre.2021.101756] [Reference Citation Analysis]
57 MacNicholas R, Olliff S, Elias E, Tripathi D. An update on the diagnosis and management of Budd-Chiari syndrome. Expert Rev Gastroenterol Hepatol. 2012;6:731-744. [PMID: 23237258 DOI: 10.1586/egh.12.56] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]